Shay Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Shay Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,000	Closed	-$287K	–	345
2024 Q1	$287K	Buy	+33,000	New	+$400K	0.04%	259

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Shay Capital's IRWD Position: Q2 2024 in Review

Shay Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 33,000 shares — an estimated $287K sold.

Shay Capital first reported a position in IRWD in Q1 2024 and held it in 1 quarter. The position peaked at $287K in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

Shay Capital reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Shay Capital sold 33,000 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $287K.
Shay Capital first reported a position in Ironwood Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Shay Capital's Ironwood Pharmaceuticals position peaked at $287K in Q1 2024.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Shay Capital's 13F filing for Q2 2024, filed 14 Aug 2024.